Please ensure Javascript is enabled for purposes of website accessibility

Why Nevro Corp. Is Soaring 10% Higher Today

By Todd Campbell - Jul 5, 2017 at 1:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company announced preliminary second-quarter financials that are reassuring investors.

What happened

Shares in Nevro Corp. (NVRO 1.55%) are rallying 10.5% at 12:30 p.m. EDT after the company gave investors an early peek at its second-quarter financials,

So what

The company is knee-deep in growth mode following the launch of Senza in 2015, a device that uses neurostimulation of the spinal cord to reduce chronic pain in patients. 

A doctor consults with a patient in a hospital bed.

IMAGE SOURCE: GETTY IMAGES.

In the second quarter, global sales are expected to officially clock in between $77.5 million to $78 million, up from $55.4 million one-year ago. Revenue in the U.S. is anticipated to be between $62.7 million and $63 million when the accounting dust settles.

For the full year, management is reaffirming its target for sales of between $310 million to $320 million. For comparison, revenue was $228.5 million in 2016, up 228% from 2015.

Now what

Marketing Senza hasn't been cheap. Operating expenses grew to $176 million in 2016 from $104 million in 2015, and while the company didn't offer up preliminary numbers on the bottom line today, heavy spending in the first quarter kept the company firmly in the red. 

In Q1, the company's investment in personnel caused operating expenses to come in 70% higher than last year. As a result, its loss from operations was $13.1 million, or $0.50 per share in the period.

While it's good news to see that the company continues to grow quickly, investors shouldn't ignore the fact that sales growth is decelerating. That's not unexpected -- at some point, however, investors will want to see a clear runway to profitability.

Todd Campbell has no position in any stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Nevro Corp. Stock Quote
Nevro Corp.
NVRO
$51.69 (1.55%) $0.79

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.